Skip to main content
Top
Published in: Infection 2/2013

01-04-2013 | Clinical and Epidemiological Study

Risk factors for non-Escherichia coli community-acquired bacteriuria

Authors: M. A. Amna, B. Chazan, R. Raz, H. Edelstein, R. Colodner

Published in: Infection | Issue 2/2013

Login to get access

Abstract

Purpose

Urinary tract infection (UTI) is one of the most common bacterial infections, with Escherichia coli causing up to 80 % of community-acquired bacteriuria (CA-Bu). The epidemiology and pathogenesis of E. coli have been intensively studied, yet, less is known about risk factors for CA-Bu due to other uropathogens. The purpose of this study was to clarify the latest knowledge.

Methods

A clinical epidemiological study among adult ambulatory patients was conducted. During November 2009, all urine cultures sent to our Microbiology Laboratory were evaluated, including demographic characteristics of the patients, underlying diseases and antibiotic treatment. Data were analysed by the SPSS statistical package.

Results

During the study period, 4,653 cultures were sent for evaluation. Of the 1,047 (22.5 %) that were positive, 838 were included in the study; 82.5 % were from females. E. coli was the most common pathogen, comprising 58.6 % of all positive cultures. By multivariate analysis, five independent risk factors were associated with non-E. coli CA-Bu: presence of foreign body in the urinary tract [odds ratio (OR) 5.8], nitrite urine test negative (OR 3.2), male gender (OR 2.5), normal erythrocyte count in urine test (OR 1.5) and recurrent UTI in the past year (OR 1.5).

Conclusions

For adult outpatients presenting with CA-Bu, five independent factors suggesting the involvement of uropathogens other than E. coli were identified. These should be taken into consideration when empiric antibiotic treatment is prescribed.
Literature
2.
go back to reference Hooton TM, Stamm WE. Diagnosis and treatment of uncomplicated urinary tract infection. Infect Dis Clin North Am. 1997;11:551–81.PubMedCrossRef Hooton TM, Stamm WE. Diagnosis and treatment of uncomplicated urinary tract infection. Infect Dis Clin North Am. 1997;11:551–81.PubMedCrossRef
3.
go back to reference Fadda G, Nicoletti G, Schito GC, Tempera G. Antimicrobial susceptibility patterns of contemporary pathogens from uncomplicated urinary tract infections isolated in a multicenter Italian survey: possible impact on guidelines. J Chemother. 2005;17:251–7.PubMed Fadda G, Nicoletti G, Schito GC, Tempera G. Antimicrobial susceptibility patterns of contemporary pathogens from uncomplicated urinary tract infections isolated in a multicenter Italian survey: possible impact on guidelines. J Chemother. 2005;17:251–7.PubMed
4.
go back to reference Foxman B, Brown P. Epidemiology of urinary tract infections: transmission and risk factors, incidence, and costs. Infect Dis Clin North Am. 2003;17:227–41.PubMedCrossRef Foxman B, Brown P. Epidemiology of urinary tract infections: transmission and risk factors, incidence, and costs. Infect Dis Clin North Am. 2003;17:227–41.PubMedCrossRef
5.
go back to reference Friedman S, Reif S, Assia A, Mishaal R, Levy I. Clinical and laboratory characteristics of non-E. coli urinary tract infections. Arch Dis Child. 2006;91:845–6.PubMedCrossRef Friedman S, Reif S, Assia A, Mishaal R, Levy I. Clinical and laboratory characteristics of non-E. coli urinary tract infections. Arch Dis Child. 2006;91:845–6.PubMedCrossRef
6.
go back to reference Marcus N, Ashkenazi S, Yaari A, Samra Z, Livni G. Non-Escherichia coli versus Escherichia coli community-acquired urinary tract infections in children hospitalized in a tertiary center: relative frequency, risk factors, antimicrobial resistance and outcome. Pediatr Infect Dis J. 2005;24:581–5.PubMedCrossRef Marcus N, Ashkenazi S, Yaari A, Samra Z, Livni G. Non-Escherichia coli versus Escherichia coli community-acquired urinary tract infections in children hospitalized in a tertiary center: relative frequency, risk factors, antimicrobial resistance and outcome. Pediatr Infect Dis J. 2005;24:581–5.PubMedCrossRef
7.
go back to reference Elsawy B, Higgins KE. The geriatric assessment. Am Fam Physician. 2011;83:48–56.PubMed Elsawy B, Higgins KE. The geriatric assessment. Am Fam Physician. 2011;83:48–56.PubMed
8.
go back to reference Weber G, Riesenberg K, Schlaeffer F, Peled N, Borer A, Yagupsky P. Changing trends in frequency and antimicrobial resistance of urinary pathogens in outpatient clinics and a hospital in Southern Israel, 1991–1995. Eur J Clin Microbiol Infect Dis. 1997;16:834–8.PubMedCrossRef Weber G, Riesenberg K, Schlaeffer F, Peled N, Borer A, Yagupsky P. Changing trends in frequency and antimicrobial resistance of urinary pathogens in outpatient clinics and a hospital in Southern Israel, 1991–1995. Eur J Clin Microbiol Infect Dis. 1997;16:834–8.PubMedCrossRef
9.
go back to reference Raz R, Hefter H, Oren B, Kennes Y, Potasman I. Antimicrobial resistance of urinary isolates in the community and its relation to antibiotic use. Isr J Med Sci. 1993;29:207–10.PubMed Raz R, Hefter H, Oren B, Kennes Y, Potasman I. Antimicrobial resistance of urinary isolates in the community and its relation to antibiotic use. Isr J Med Sci. 1993;29:207–10.PubMed
10.
go back to reference Daza R, Gutiérrez J, Piédrola G. Antibiotic susceptibility of bacterial strains isolated from patients with community-acquired urinary tract infections. Int J Antimicrob Agents. 2001;18:211–5.PubMedCrossRef Daza R, Gutiérrez J, Piédrola G. Antibiotic susceptibility of bacterial strains isolated from patients with community-acquired urinary tract infections. Int J Antimicrob Agents. 2001;18:211–5.PubMedCrossRef
11.
go back to reference Schito GC, Naber KG, Botto H, Palou J, Mazzei T, Gualco L, Marchese A. The ARESC study: an international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections. Int J Antimicrob Agents. 2009;34:407–13.PubMedCrossRef Schito GC, Naber KG, Botto H, Palou J, Mazzei T, Gualco L, Marchese A. The ARESC study: an international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections. Int J Antimicrob Agents. 2009;34:407–13.PubMedCrossRef
12.
go back to reference Goldstein FW. Antibiotic susceptibility of bacterial strains isolated from patients with community-acquired urinary tract infections in France. Multicentre Study Group. Eur J Clin Microbiol Infect Dis. 2000;19:112–7.PubMedCrossRef Goldstein FW. Antibiotic susceptibility of bacterial strains isolated from patients with community-acquired urinary tract infections in France. Multicentre Study Group. Eur J Clin Microbiol Infect Dis. 2000;19:112–7.PubMedCrossRef
13.
go back to reference Farrell DJ, Morrissey I, De Rubeis D, Robbins M, Felmingham D. A UK multicentre study of the antimicrobial susceptibility of bacterial pathogens causing urinary tract infection. J Infect. 2003;46:94–100.PubMedCrossRef Farrell DJ, Morrissey I, De Rubeis D, Robbins M, Felmingham D. A UK multicentre study of the antimicrobial susceptibility of bacterial pathogens causing urinary tract infection. J Infect. 2003;46:94–100.PubMedCrossRef
14.
go back to reference Stratchounski LS, Rafalski VV. Antimicrobial susceptibility of pathogens isolated from adult patients with uncomplicated community-acquired urinary tract infections in the Russian Federation: two multicentre studies, UTIAP-1 and UTIAP-2. Int J Antimicrob Agents. 2006;28:S4–9.PubMedCrossRef Stratchounski LS, Rafalski VV. Antimicrobial susceptibility of pathogens isolated from adult patients with uncomplicated community-acquired urinary tract infections in the Russian Federation: two multicentre studies, UTIAP-1 and UTIAP-2. Int J Antimicrob Agents. 2006;28:S4–9.PubMedCrossRef
15.
go back to reference Zhanel GG, Hisanaga TL, Laing NM, DeCorby MR, Nichol KA, Weshnoweski B, Johnson J, Noreddin A, Low DE, Karlowsky JA; for the NAUTICA Group, Hoban DJ. Antibiotic resistance in Escherichia coli outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA). Int J Antimicrob Agents. 2006;27:468–75.PubMedCrossRef Zhanel GG, Hisanaga TL, Laing NM, DeCorby MR, Nichol KA, Weshnoweski B, Johnson J, Noreddin A, Low DE, Karlowsky JA; for the NAUTICA Group, Hoban DJ. Antibiotic resistance in Escherichia coli outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA). Int J Antimicrob Agents. 2006;27:468–75.PubMedCrossRef
16.
go back to reference Kiffer CR, Mendes C, Oplustil CP, Sampaio JL. Antibiotic resistance and trend of urinary pathogens in general outpatients from a major urban city. Int Braz J Urol. 2007;33:42–8; discussion 49.PubMedCrossRef Kiffer CR, Mendes C, Oplustil CP, Sampaio JL. Antibiotic resistance and trend of urinary pathogens in general outpatients from a major urban city. Int Braz J Urol. 2007;33:42–8; discussion 49.PubMedCrossRef
17.
go back to reference Ronald A. The etiology of urinary tract infection: traditional and emerging pathogens. Dis Mon. 2003;49:71–82.PubMedCrossRef Ronald A. The etiology of urinary tract infection: traditional and emerging pathogens. Dis Mon. 2003;49:71–82.PubMedCrossRef
18.
go back to reference Tabibian JH, Gornbein J, Heidari A, Dien SL, Lau VH, Chahal P, Churchill BM, Haake DA. Uropathogens and host characteristics. J Clin Microbiol. 2008;46:3980–6.PubMedCrossRef Tabibian JH, Gornbein J, Heidari A, Dien SL, Lau VH, Chahal P, Churchill BM, Haake DA. Uropathogens and host characteristics. J Clin Microbiol. 2008;46:3980–6.PubMedCrossRef
19.
go back to reference Warren JW, Tenney JH, Hoopes JM, Muncie HL, Anthony WC. A prospective microbiologic study of bacteriuria in patients with chronic indwelling urethral catheters. J Infect Dis. 1982;146:719–23.PubMedCrossRef Warren JW, Tenney JH, Hoopes JM, Muncie HL, Anthony WC. A prospective microbiologic study of bacteriuria in patients with chronic indwelling urethral catheters. J Infect Dis. 1982;146:719–23.PubMedCrossRef
20.
go back to reference Meier S, Weber R, Zbinden R, Ruef C, Hasse B. Extended-spectrum β-lactamase-producing gram-negative pathogens in community-acquired urinary tract infections: an increasing challenge for antimicrobial therapy. Infection. 2011;39:333–40.PubMedCrossRef Meier S, Weber R, Zbinden R, Ruef C, Hasse B. Extended-spectrum β-lactamase-producing gram-negative pathogens in community-acquired urinary tract infections: an increasing challenge for antimicrobial therapy. Infection. 2011;39:333–40.PubMedCrossRef
21.
go back to reference Raz R, Okev N, Kennes Y, Gilboa A, Lavi I, Bisharat N. Demographic characteristics of patients with community-acquired bacteriuria and susceptibility of urinary pathogens to antimicrobials in northern Israel. Isr Med Assoc J. 2000;2:426–9.PubMed Raz R, Okev N, Kennes Y, Gilboa A, Lavi I, Bisharat N. Demographic characteristics of patients with community-acquired bacteriuria and susceptibility of urinary pathogens to antimicrobials in northern Israel. Isr Med Assoc J. 2000;2:426–9.PubMed
22.
go back to reference Felmingham D, Wilson AP, Quintana AI, Grüneberg RN. Enterococcus species in urinary tract infection. Clin Infect Dis. 1992;15:295–301.PubMedCrossRef Felmingham D, Wilson AP, Quintana AI, Grüneberg RN. Enterococcus species in urinary tract infection. Clin Infect Dis. 1992;15:295–301.PubMedCrossRef
23.
go back to reference Raz R, Merzbach D, Sobel J, Finkelstein R. Absence of Staphylococcus saprophyticus in urinary tract infections in Israel. Isr J Med Sci. 1983;19:566–7.PubMed Raz R, Merzbach D, Sobel J, Finkelstein R. Absence of Staphylococcus saprophyticus in urinary tract infections in Israel. Isr J Med Sci. 1983;19:566–7.PubMed
24.
go back to reference Raz R, Colodner R, Kunin CM. Who are you—Staphylococcus saprophyticus? Clin Infect Dis. 2005;40:896–8.PubMedCrossRef Raz R, Colodner R, Kunin CM. Who are you—Staphylococcus saprophyticus? Clin Infect Dis. 2005;40:896–8.PubMedCrossRef
25.
go back to reference Puhto T, Ylipalosaari P, Ohtonen P, Syrjala H. Point prevalence and risk factors for healthcare-associated infections in primary healthcare wards. Infection. 2011;39:217–23.PubMedCrossRef Puhto T, Ylipalosaari P, Ohtonen P, Syrjala H. Point prevalence and risk factors for healthcare-associated infections in primary healthcare wards. Infection. 2011;39:217–23.PubMedCrossRef
Metadata
Title
Risk factors for non-Escherichia coli community-acquired bacteriuria
Authors
M. A. Amna
B. Chazan
R. Raz
H. Edelstein
R. Colodner
Publication date
01-04-2013
Publisher
Springer-Verlag
Published in
Infection / Issue 2/2013
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-012-0347-1

Other articles of this Issue 2/2013

Infection 2/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.